Table 4 Elixhauser index comorbidities (%) for study cohorts
From: Predictive performance of comorbidity measures in administrative databases for diabetes cohorts
Comorbidity | Cohort 1a(n= 29,058) | Cohort 2 (n= 41,925) |
|---|---|---|
Hypertension- uncomplicated | 33.3 | 42.7 |
Diabetes- uncomplicated | 14.7 | 14.7 |
Chronic pulmonary disease | 13.9 | 13.5 |
Congestive heart failure | 8.0 | 8.0 |
Depression | 5.8 | 6.0 |
Solid tumors | 5.0 | 5.4 |
Diabetes- complicated | 3.2 | 3.0 |
Psychiatric | 2.4 | 2.7 |
Cardiac arrhythmias | 2.3 | 2.8 |
Fluid and electrolyte disorders | 1.9 | 2.7 |
RA/collagen vascular disease | 1.9 | 1.9 |
Renal failure | 1.8 | 3.1 |
Valvular disease | 1.5 | 2.2 |
Peripheral vascular disease | 1.4 | 1.5 |
Metastatic cancer | 1.3 | 1.7 |
Other neurological disorders | 1.1 | 1.2 |
Coagulopathy | 1.0 | 2.5 |
Hypertension- complicated | 0.7 | 1.0 |
Pulmonary circulatory disorders | 0.7 | 0.8 |
Liver disease | 0.6 | 0.7 |
Obesity | 0.6 | 1.0 |
Paraplegia | 0.6 | 0.4 |
Deficiency anemia | 0.5 | 0.8 |
Alcohol abuse | 0.4 | 0.7 |
Hypothyroidism | 0.4 | 1.1 |
Drug abuse | 0.3 | 0.4 |
Peptic ulcer disease | 0.3 | 0.4 |
Lymphoma | 0.2 | 0.2 |
Weight loss | 0.1 | 0.2 |
AIDS | <0.1 | <0.1 |
Blood loss anemia | 0.0 | <0.1 |
1 or more Elixhauser comorbidities | 61.4 | 65.5 |